Fish Oil
- 6 June 2011
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 25 (1) , 69-74
Abstract
Fish and fish oil supplements are often used to lower triglycerides; however, recent studies suggest the beneficial use of fish oil for other cardiovascular reasons. Studies have shown that in addition to decreasing triglycerides, fish oil has shown benefit in providing antiplatelet activity, improving heart failure, and improving vascular function in diabetes. Fish oil was shown to improve triglycerides in combination with other lipid-lowering therapy such as a statin or fibrate. Fish oil also had effects on lowering total cholesterol, very-low-density lipoprotein (VLDL), and increasing high-density lipoprotein (HDL). In terms of its antiplatelet activity, fish oil was shown to lower platelet aggregation when given in combination with clopidogrel and aspirin therapy during PCI, thus fish oil appears to enhance platelet response to clopidogrel. Fish oil has a role in heart failure as well. Fish oil was shown to slightly decrease morbidity and mortality in patients with class II-IV heart failure compared to placebo. Finally, fish oil showed benefit in patients with type II diabetes in terms of improving micro- and macrovascular function.Keywords
This publication has 14 references indexed in Scilit:
- Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary InterventionJACC, 2010
- Effects of n–3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitusThe American Journal of Clinical Nutrition, 2010
- Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patientsCurrent Medical Research and Opinion, 2010
- Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of AtorvastatinMayo Clinic Proceedings, 2010
- Effects of n-3 Polyunsaturated Fatty Acid Therapy on Plasma Inflammatory Markers and N-Terminal Pro-brain Natriuretic Peptide in Elderly Patients with Chronic Heart FailureJournal of International Medical Research, 2009
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic SubjectsJournal of Cardiovascular Pharmacology, 2009
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trialThe Lancet, 1999
- EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)The Lancet, 1989